Clinical trial · Observational
Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer
Association Between Respiratory Muscle Performance and Functional Capacity in Patients With Primary Stage IIIb & IV Lung Cancer
NCT01078883CI-TRIAL-00004266unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of our study is to investigate the association between respiratory muscle performance, functional capacity, dyspnea, anxiety/depression symptom, 1-year respiratory morbidity rate, and 1-year mortality in patients with primary stage IIIb and IV lung cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Lung cancer
- description
- Patients with primary stage IIIb and IV lung cancer
Primary outcomes (1)
- measure
- 1-year respiratory morbidity rate and 1-year mortality rate
- timeFrame
- 1 year
Secondary outcomes (1)
- measure
- respiratory muscle performance, functional capacity, dyspnea, anxiety/depression symptom
- timeFrame
- 1-2 days
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of stage IIIb/V lung cancer * Normal cognition (a Mini Mental State Examination score of more than/equal to 24 points) * Able to finish all tests Exclusion Criteria: * A clinical diagnosis affecting respiratory muscle function and functional activity performance (e.g. acute pneumonia)
References
Publications (0)
Data not yet available
No reference posted for this study.